285 related articles for article (PubMed ID: 27144725)
1. Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
Rastogi V; Honnavar P; Rudramurthy SM; Pamidi U; Ghosh A; Chakrabarti A
Mycoses; 2016 Aug; 59(8):528-34. PubMed ID: 27144725
[TBL] [Abstract][Full Text] [Related]
2. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
Francisco EC; de Almeida Junior JN; de Queiroz Telles F; Aquino VR; Mendes AVA; de Andrade Barberino MGM; de Tarso O Castro P; Guimarães T; Hahn RC; Padovan ACB; Chaves GM; Colombo AL
Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116
[TBL] [Abstract][Full Text] [Related]
3. Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina.
Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G; Bosco-Borgeat ME
Med Mycol; 2014 May; 52(4):356-66. PubMed ID: 24682113
[TBL] [Abstract][Full Text] [Related]
4. Invasive Infections Due to
Guo LN; Yu SY; Hsueh PR; Al-Hatmi AMS; Meis JF; Hagen F; Xiao M; Wang H; Barresi C; Zhou ML; de Hoog GS; Xu YC
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463892
[TBL] [Abstract][Full Text] [Related]
5. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
6. Sequence-based identification, genotyping and EUCAST antifungal susceptibilities of Trichosporon clinical isolates from Greece.
Arabatzis M; Abel P; Kanellopoulou M; Adamou D; Alexandrou-Athanasoulis H; Stathi A; Platsouka E; Milioni A; Pangalis A; Velegraki A
Clin Microbiol Infect; 2014 Aug; 20(8):777-83. PubMed ID: 24330082
[TBL] [Abstract][Full Text] [Related]
7. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.
Iturrieta-González IA; Padovan AC; Bizerra FC; Hahn RC; Colombo AL
PLoS One; 2014; 9(10):e109553. PubMed ID: 25360765
[TBL] [Abstract][Full Text] [Related]
8. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen.
Dabas Y; Xess I; Kale P
Med Mycol; 2017 Jul; 55(5):518-527. PubMed ID: 27816903
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and Antifungal Susceptibility of Infections Caused by
Singh S; Capoor MR; Varshney S; Gupta DK; Verma PK; Ramesh V
Indian J Med Microbiol; 2019; 37(4):536-541. PubMed ID: 32436877
[TBL] [Abstract][Full Text] [Related]
10. Molecular Identification, Genotyping, Phenotyping, and Antifungal Susceptibilities of Medically Important Trichosporon, Apiotrichum, and Cutaneotrichosporon Species.
do Espírito Santo EPT; Monteiro RC; da Costa ARF; Marques-da-Silva SH
Mycopathologia; 2020 Apr; 185(2):307-317. PubMed ID: 31776790
[TBL] [Abstract][Full Text] [Related]
11. First genotype identification of Trichosporon asahii in Sfax, Tunisia.
Sellami H; Trabelsi H; Neji S; Amouri I; Cheikhrouhou F; Makni F; Ayadi A
J Med Microbiol; 2017 Apr; 66(4):397-401. PubMed ID: 28141498
[TBL] [Abstract][Full Text] [Related]
12. Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients.
Montoya AM; Sánchez González A; Palma-Nicolás JP; Gómez-Treviño A; González JG; González GM
Med Mycol; 2015 Jun; 53(5):505-11. PubMed ID: 25980003
[TBL] [Abstract][Full Text] [Related]
13. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
Tsai MS; Yang YL; Wang AH; Wang LS; Lu DC; Liou CH; Hsieh LY; Wu CJ; Cheng MF; Shi ZY; Lo HJ
Mycopathologia; 2012 Aug; 174(2):121-30. PubMed ID: 22318636
[TBL] [Abstract][Full Text] [Related]
14. Cutaneotrichosporon (Trichosporon) debeurmannianum: A Rare Yeast Isolated from Blood and Urine Samples.
Nath R; Sargiary P; Borkakoty B; Parida P
Mycopathologia; 2018 Jun; 183(3):585-590. PubMed ID: 29196924
[TBL] [Abstract][Full Text] [Related]
15. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
16. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.
Xia Z; Yang R; Wang W; Cong L
Mycopathologia; 2012 Mar; 173(2-3):127-33. PubMed ID: 21979867
[TBL] [Abstract][Full Text] [Related]
17. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing.
Chagas-Neto TC; Chaves GM; Melo AS; Colombo AL
J Clin Microbiol; 2009 Apr; 47(4):1074-81. PubMed ID: 19225102
[TBL] [Abstract][Full Text] [Related]
18. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Araujo Ribeiro M; Alastruey-Izquierdo A; Gomez-Lopez A; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2008 Dec; 25(4):221-5. PubMed ID: 19071890
[TBL] [Abstract][Full Text] [Related]
19. Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
Hazirolan G; Canton E; Sahin S; Arikan-Akdagli S
Antimicrob Agents Chemother; 2013 Oct; 57(10):4841-7. PubMed ID: 23877683
[TBL] [Abstract][Full Text] [Related]
20. Intergenic spacer (IGS-1) region sequence-based identification, genotypic analysis, and antifungal susceptibility of clinical Trichosporon species.
Parashar A; Rastogi V; Prakash H; Pandey A; Rudramurthy SM
Indian J Med Microbiol; 2023; 45():100390. PubMed ID: 37573054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
